HK1008303A1 - Stable liquid compositions of gamma interferon - Google Patents

Stable liquid compositions of gamma interferon

Info

Publication number
HK1008303A1
HK1008303A1 HK98109265A HK98109265A HK1008303A1 HK 1008303 A1 HK1008303 A1 HK 1008303A1 HK 98109265 A HK98109265 A HK 98109265A HK 98109265 A HK98109265 A HK 98109265A HK 1008303 A1 HK1008303 A1 HK 1008303A1
Authority
HK
Hong Kong
Prior art keywords
stable liquid
gamma
liquid compositions
gamma interferon
ifn
Prior art date
Application number
HK98109265A
Other languages
English (en)
Inventor
Tue Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1008303A1 publication Critical patent/HK1008303A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
HK98109265A 1993-05-12 1998-07-20 Stable liquid compositions of gamma interferon HK1008303A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6032793A 1993-05-12 1993-05-12
PCT/US1994/004928 WO1994026302A1 (en) 1993-05-12 1994-05-04 Stable liquid compositions of gamma interferon

Publications (1)

Publication Number Publication Date
HK1008303A1 true HK1008303A1 (en) 1999-05-07

Family

ID=22028807

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109265A HK1008303A1 (en) 1993-05-12 1998-07-20 Stable liquid compositions of gamma interferon

Country Status (23)

Country Link
EP (1) EP0697887B1 (ko)
JP (1) JP4053586B2 (ko)
KR (1) KR100330325B1 (ko)
CN (1) CN1120724C (ko)
AT (1) ATE173632T1 (ko)
AU (1) AU683469B2 (ko)
CA (1) CA2159602C (ko)
CZ (1) CZ285389B6 (ko)
DE (1) DE69414841T2 (ko)
DK (1) DK0697887T3 (ko)
ES (1) ES2126114T3 (ko)
FI (1) FI111442B (ko)
GR (1) GR3029286T3 (ko)
HK (1) HK1008303A1 (ko)
HU (1) HUT72980A (ko)
IL (1) IL109350A (ko)
NO (1) NO320069B1 (ko)
NZ (1) NZ266354A (ko)
PL (1) PL176079B1 (ko)
SK (1) SK280958B6 (ko)
TW (1) TW275585B (ko)
WO (1) WO1994026302A1 (ko)
ZA (1) ZA942955B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2758154B2 (ja) * 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
CN1126567C (zh) * 1995-11-07 2003-11-05 基因技术股份有限公司 稳定的神经生长因子组合物及其试剂盒和制备方法
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
JP3493866B2 (ja) * 1995-12-27 2004-02-03 ライオン株式会社 発泡性口腔用組成物
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
EP0920306A2 (en) 1996-07-12 1999-06-09 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
CN1733296B (zh) * 1996-12-24 2010-05-26 拜奥根Idec马萨诸塞公司 稳定的液体干扰素制剂
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7070799B1 (en) 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO2001072278A2 (en) * 2000-03-30 2001-10-04 Generex Pharmaceuticals Inc. Method for administering insulin to the buccal region
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US20040156835A1 (en) * 2001-05-30 2004-08-12 Taiji Imoto Protein preparation
EP1516627A1 (en) * 2003-09-17 2005-03-23 CONARIS research institute AG Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
JP5137055B2 (ja) * 2006-03-10 2013-02-06 塩野義製薬株式会社 安定化されたインターフェロン−γ組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257956B2 (en) * 1986-08-19 2000-11-22 Genentech, Inc. Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation

Also Published As

Publication number Publication date
FI111442B (fi) 2003-07-31
FI955136A0 (fi) 1995-10-27
GR3029286T3 (en) 1999-05-28
CZ295595A3 (en) 1996-04-17
CN1120724C (zh) 2003-09-10
NZ266354A (en) 1997-06-24
CA2159602C (en) 2008-08-26
KR960702320A (ko) 1996-04-27
ZA942955B (en) 1995-10-30
IL109350A0 (en) 1994-07-31
DK0697887T3 (da) 1999-08-09
IL109350A (en) 2001-01-28
AU6782294A (en) 1994-12-12
JP4053586B2 (ja) 2008-02-27
CZ285389B6 (cs) 1999-07-14
WO1994026302A1 (en) 1994-11-24
KR100330325B1 (ko) 2002-11-01
JPH08510242A (ja) 1996-10-29
DE69414841T2 (de) 1999-06-02
PL176079B1 (pl) 1999-04-30
SK280958B6 (sk) 2000-10-09
EP0697887A1 (en) 1996-02-28
CN1122575A (zh) 1996-05-15
AU683469B2 (en) 1997-11-13
TW275585B (ko) 1996-05-11
FI955136A (fi) 1995-10-27
DE69414841D1 (de) 1999-01-07
PL311639A1 (en) 1996-03-04
HU9503223D0 (en) 1996-01-29
ES2126114T3 (es) 1999-03-16
NO954544D0 (no) 1995-11-10
EP0697887B1 (en) 1998-11-25
NO954544L (no) 1995-11-10
CA2159602A1 (en) 1994-11-24
NO320069B1 (no) 2005-10-17
SK137895A3 (en) 1997-02-05
ATE173632T1 (de) 1998-12-15
HUT72980A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
TW275585B (ko)
TW229208B (ko)
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
UA32525C2 (uk) Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
IL103510A0 (en) Pharmaceutical compositions containing antibodies for causing immunosuppression
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
HU9203871D0 (en) Pharmaceutical application of certain cistine derivatives
ES479423A1 (es) Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina.
GB2251188B (en) Drug delivery system comprising a lysophosphoglycerolipid
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
WO2001018039A3 (en) INCREASED PRODUCTION OF INTERFERON-$g(a)
ZA9364B (en) Pyridysulphonylure compound, processes for the preparation thereof, and pharmaceutical compositions containing it
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
ITRM920551A1 (it) Composizioni farmaceutiche somministrabili per via intranasale contenenti calcitonina quale principio attivo.
IT1244601B (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina
JO1711B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20140503